文献速递乳腺癌

低风险乳腺癌的放射治疗:全乳、部分或不做?

Radiation Therapy for Low-Risk Breast Cancer: Whole, Partial, or None?
PubMed 文献 · J Clin Oncol · 2022-11-04

本文以一名低风险、激素受体阳性/HER2阴性、早期左侧乳腺癌绝经后患者为例,讨论广泛局部切除和前哨淋巴结活检后术后放疗的选择,包括省略放疗、加速部分乳腺照射、全乳放疗及各方案剂量分割细节,并结合本期发表的丹麦乳腺癌协作组部分乳腺照射试验及其他关键试验进行综述。

要点

  • 低风险早期乳腺癌术后放疗选择包括省略放疗、加速部分乳腺照射和全乳放疗。
  • 丹麦乳腺癌协作组部分乳腺照射试验为部分乳腺照射提供了新的证据。
  • 本例患者最终决定采用与丹麦乳腺癌协作组部分乳腺照射试验一致的中度低分割部分乳腺照射(40 Gy/15次)。

核心结论

  • 本文结合丹麦乳腺癌协作组部分乳腺照射试验及其他关键试验,综述了低风险早期乳腺癌术后放疗的选择谱系及剂量分割方案。

研究设计与样本

  • 本文为肿瘤学大查房系列综述,以病例展示引入,随后描述诊断与管理挑战、复习相关文献并总结作者建议的管理方法。

主要发现

  • 病例为一名绝经后女性,表现为低风险、雌激素受体阳性/孕激素受体阳性/人表皮生长因子受体2阴性、早期左侧乳腺癌,讨论广泛局部切除和前哨淋巴结活检后术后放疗的作用。
  • 讨论的放疗选择包括省略放疗、加速部分乳腺照射、全乳放疗以及各方案不同的剂量/分割方案细节。
  • 经考虑临床病理特征、现有数据及患者偏好/目标后,决定采用与丹麦乳腺癌协作组部分乳腺照射试验一致的中度低分割部分乳腺照射(40 Gy/15次)。

临床怎么用

  • 作者在本例中考虑临床病理特征、现有数据及患者偏好/目标后,决定给予与丹麦乳腺癌协作组部分乳腺照射试验一致的中度低分割部分乳腺照射(40 Gy/15次)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.The following case represents a relatively common clinical scenario of a postmenopausal female patient who presents with low-risk, estrogen receptor-positive/progesterone receptor-positive/human epidermal growth factor receptor 2-negative, early-stage, left-sided breast cancer to discuss the role of postoperative radiation (RT) following wide local excision (WLE) and sentinel node biopsy. The spectrum of choices, ranging from omission of RT, accelerated partial breast irradiation (PBI), whole-breast radiation therapy, and the nuances of various dose/fractionation regimens for each option, are discussed in the context of the Danish Breast Cancer Study Group (DBCSG) PBI trial published in this issue, with additional review of other key trials that inform these treatment recommendations. After consideration of the clinical-pathologic features in the framework of the existing data and an in-depth discussion taking into consideration the patient's preferences/goals, the decision was made to deliver moderately hypofractionated RT (40 Gy/15 fractions) to a PBI volume, in concordance with the DBCSG-PBI trial.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Moran MS, Ho AY. Radiation Therapy for Low-Risk Breast Cancer: Whole, Partial, or None? J Clin Oncol. 2022. PMID: 36332170. doi:10.1200/JCO.22.01751

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。